Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 4.00M | $18.0M | 8.02% | -- | 2026-06-30 |
| BVF INC/IL | 3.24M | $14.0M | 6.49% | +1.26M | 2026-06-30 |
| ACORN CAPITAL ADVISORS, LLC | 2.84M | $12.0M | 5.69% | -- | 2026-06-30 |
| StepStone Group LP | 2.66M | $12.0M | 5.34% | -- | 2026-06-30 |
| ADAR1 Capital Management, LLC | 2.24M | $10.0M | 4.49% | -196.3K | 2026-06-30 |
| Vivo Capital, LLC | 1.93M | $8.0M | 3.87% | -- | 2026-06-30 |
| Vestal Point Capital, LP | 1.83M | $8.0M | 3.66% | -14.1K | 2026-06-30 |
| BlackRock, Inc. | 1.50M | $6.0M | 3.01% | +1.45M | 2026-06-30 |
| Trails Edge Capital Partners, LP | 1.44M | $6.0M | 2.88% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.44M | $6.0M | 2.88% | +854.6K | 2026-06-30 |
